Access across
the world
Evidence-based testing for the detection and identification of infectious diseases
Mayo Clinic’s internationally renowned clinical microbiology laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases.
Our laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
3 million
tests performed annually
70
years of diagnosing and treating infectious diseases
7
specialized laboratories performing infectious disease testing
24/7
support from Mayo Clinic physicians and scientists
Physician-led subspecialized laboratories
Our laboratories are managed by physicians and scientists with expert knowledge regarding the clinical implications of each test result and how it can impact patient care.
The right tests, not the most tests
Our clinicians and laboratorians focus on maintaining high-quality, cost-effective, and efficient care by using algorithmic, evidence-based approaches that lead to correct diagnoses and treatment while minimizing unnecessary testing.
Access across
the globe
Every laboratory offers testing. But at Mayo Clinic Laboratories, in addition to our comprehensive testing menu, we offer a service that allow patients access to Mayo Clinic experts from across the world.
COVID-19 Resource Center
We are rapidly expanding our COVID-19 testing to provide accurate information for health care professionals on the front lines of this crisis. We will continue coordinating closely with state and federal officials to offer testing in the areas with the greatest need.
The Latest
Recognizing Dr. Pritt’s innovative work in medical education, the Infectious Diseases Society of America is highlighting her role as an educator in its monthly series.
Audrey Schuetz, M.D., provides a detailed overview of Mayo Clinic Laboratories’ new culture-based extended spectrum beta lactamase (ESBL) testing. Used to screen for the presence of multi-drug resistant gram-negative bacteria in donor stool intended for fecal microbiota transplantation, the screening test is performed on stool or swab samples taken from around the anus to detect potentially harmful ESBL bacteria that could jeopardize the outcomes of fecal microbiota transplants -- especially in patients who carry the bacteria in their gut without getting sick.
PACE - In this month’s “Virtual Lecture,” Robin Patel, M.D., discusses a new non-invasive approach to diagnosis of Helicobacter pylori infection that also assesses antimicrobial resistance.
Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV. RSV — which poses significant risks for infants and patients with underlying health conditions — can be treated if diagnosed early.
If you need a test for COVID-19, a variety of options are now available. But how do you know which one is right for you? Use this guide from Mayo Clinic Laboratories to sort through the choices and help you decide.